Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Thromboplastin time, partial (PTT); plasma or whole blood

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85730 refers to the laboratory test known as the partial thromboplastin time (PTT), which can be performed on either plasma or whole blood samples. This test is crucial in the assessment of the blood's ability to clot properly and is often utilized in various clinical scenarios. Commonly referred to as activated PTT or aPTT, this test is primarily conducted to diagnose the underlying causes of bleeding disorders or as a precautionary measure before surgical procedures to exclude any potential coagulation defects. The methodology involves mixing a specific reagent containing silica and synthetic phospholipids with the patient's plasma. The silica acts as a negatively charged surface that activates the contact pathway of the coagulation cascade. Following this activation, calcium chloride is added to the mixture to initiate the clotting process. The time taken for clot formation is then measured using photo-optical methods, providing a quantitative assessment of the coagulation status. In cases where the PTT results are elevated and the patient is not on anticoagulant therapy, a follow-up test known as a PTT mixing study may be indicated. This involves mixing the patient's plasma with normal plasma in a 1:1 ratio and re-evaluating the clotting time. The outcomes of this mixing study can help determine whether the elevation in PTT is due to the presence of an inhibitor, such as lupus anticoagulant, or a deficiency in coagulation factors.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The partial thromboplastin time (PTT) test, represented by CPT® Code 85730, is indicated for several clinical scenarios, including:

  • Diagnosis of Bleeding Disorders This test is performed to identify the underlying causes of unexplained bleeding or bruising in patients, helping to determine if there are any coagulation abnormalities present.
  • Surgical Screening PTT may be utilized as a preoperative screening tool to rule out potential coagulation defects in patients scheduled for surgery, ensuring that they have adequate clotting ability to minimize the risk of excessive bleeding during and after the procedure.

2. Procedure

The procedure for conducting the partial thromboplastin time (PTT) test involves several key steps, which are detailed as follows:

  • Step 1: Sample Collection A blood sample is collected from the patient, which can be either plasma or whole blood, depending on the specific requirements of the test.
  • Step 2: Reagent Preparation A reagent containing silica and synthetic phospholipids is prepared. The silica serves as a negatively charged particulate surface that activates the contact pathway of the coagulation cascade.
  • Step 3: Mixing The prepared reagent is mixed with the patient’s plasma in a controlled environment to initiate the coagulation process.
  • Step 4: Activation of Clotting Calcium chloride is added to the mixture, which triggers the clotting process, allowing for the formation of a clot.
  • Step 5: Measurement The time taken for clot formation is measured using photo-optical methods, providing a quantitative result that reflects the patient’s coagulation status.

3. Post-Procedure

After the PTT test is completed, the results are analyzed to determine the clotting time. If the PTT is found to be elevated and the patient is not on anticoagulant medication, a follow-up PTT mixing study may be performed. This involves mixing the patient’s plasma with normal plasma in a 1:1 ratio and incubating the mixture before measuring the clotting time again. The results of this mixing study can provide further insights into whether the elevated PTT is due to the presence of an inhibitor or a deficiency in coagulation factors. It is essential for healthcare providers to interpret the results in conjunction with the patient's clinical history and other laboratory findings to make informed decisions regarding further diagnostic or therapeutic interventions.

Short Descr THROMBOPLASTIN TIME PARTIAL
Medium Descr THROMBOPLASTIN TIME PARTIAL PLASMA/WHOLE BLOOD
Long Descr Thromboplastin time, partial (PTT); plasma or whole blood
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 4
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GA Waiver of liability statement issued as required by payer policy, individual case
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
GZ Item or service expected to be denied as not reasonable and necessary
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
Q4 Service for ordering/referring physician qualifies as a service exemption
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
GW Service not related to the hospice patient's terminal condition
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
GX Notice of liability issued, voluntary under payer policy
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
51 Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d).
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
CC Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed)
GC This service has been performed in part by a resident under the direction of a teaching physician
PD Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days
Q0 Investigational clinical service provided in a clinical research study that is in an approved clinical research study
Q6 Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area
QJ Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b)
QW Clia waived test
SA Nurse practitioner rendering service in collaboration with a physician
TC Technical component; under certain circumstances, a charge may be made for the technical component alone; under those circumstances the technical component charge is identified by adding modifier 'tc' to the usual procedure number; technical component charges are institutional charges and not billed separately by physicians; however, portable x-ray suppliers only bill for technical component and should utilize modifier tc; the charge data from portable x-ray suppliers will then be used to build customary and prevailing profiles
X5 Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician
XE Separate encounter, a service that is distinct because it occurred during a separate encounter
Date
Action
Notes
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"